178 related articles for article (PubMed ID: 31520428)
1. Epidemiology of Kawasaki disease before and after universal Bacille Calmette-Guérin vaccination program was discontinued.
Pasma H; Honkila M; Pokka T; Renko M; Salo E; Tapiainen T
Acta Paediatr; 2020 Apr; 109(4):842-846. PubMed ID: 31520428
[TBL] [Abstract][Full Text] [Related]
2. Analysis of factors associated with development of Bacille Calmette-Guérin inoculation site change in patients with Kawasaki disease.
Araki T; Kodera A; Kitada K; Fujiwara M; Muraoka M; Abe Y; Ikeda M; Tsukahara H
J Int Med Res; 2018 Apr; 46(4):1640-1648. PubMed ID: 29512398
[TBL] [Abstract][Full Text] [Related]
3. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
Kontturi A; Soini H; Ollgren J; Salo E
Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
[TBL] [Abstract][Full Text] [Related]
6. Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
Garrido-García LM; Castillo-Moguel A; Vázquez-Rivera M; Cravioto P; Fernando G
Pediatr Infect Dis J; 2017 Oct; 36(10):e237-e241. PubMed ID: 28498302
[TBL] [Abstract][Full Text] [Related]
7. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
8. Two infants with tuberculid associated with Kawasaki disease.
Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
[TBL] [Abstract][Full Text] [Related]
10. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.
Lai CC; Lee PC; Wang CC; Hwang BT; Meng CC; Tsai MC
Pediatr Neonatol; 2013 Feb; 54(1):43-8. PubMed ID: 23445742
[TBL] [Abstract][Full Text] [Related]
11. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.
Jackson S; Kabir Z; Comiskey C
Vaccine; 2024 Mar; 42(8):2099-2105. PubMed ID: 38423810
[TBL] [Abstract][Full Text] [Related]
12. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
Loh ACE; Kua PHJ; Tan ZL
Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of Kawasaki disease after simultaneous immunization.
Matsubara D; Minami T; Seki M; Tamura D; Yamagata T
Pediatr Int; 2019 Nov; 61(11):1171-1173. PubMed ID: 31709668
[No Abstract] [Full Text] [Related]
14. Multisystem inflammatory syndrome in children associated with Bacille Calmette-Guérin scar: a case presentation.
Kizildag H; Hannavi KJ; Gur R; Oztarhan K
BMC Pediatr; 2023 Mar; 23(1):92. PubMed ID: 36859277
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease in children with Bacillus Calmette-Guérin scar reactivity: Focus on coronary outcomes.
Yang MC; Wu KL; Huang CN; Liu YC; Chien YH; Fu CM; Lim HK; Chin CY; Wu JR; Liu HM; Sun LC; Lee CY; Su YH; Wang YF; Lin MT
J Formos Med Assoc; 2023 Oct; 122(10):1001-1007. PubMed ID: 37142476
[TBL] [Abstract][Full Text] [Related]
16. The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study.
Hall GC; Tulloh RM; Tulloh LE
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1331-1336. PubMed ID: 27651105
[TBL] [Abstract][Full Text] [Related]
17. Paediatric tuberculosis during universal and selective
Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
Novais C; Fortunato F; Bicho A; Preto L
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033285
[TBL] [Abstract][Full Text] [Related]
20. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
